Report
Ole Martin Westgaard
EUR 87.07 For Business Accounts Only

Aker Biomarine (Hold, TP: NOK54.00) - Krilling me softly

We are slightly below consensus ahead of the Q2 report (due at 07:00 CET on 14 July). Revenues are set to be down slightly YOY as we expect a recovery in krill oil volumes and Qrill Aqua, offset by continued low volumes in South Korea and a sluggish US retail market for Brands. We reiterate our HOLD and NOK54 target price.
Underlying
Aker BioMarine

Provider
DnB Markets
DnB Markets

DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.

 

Analysts
Ole Martin Westgaard

Other Reports on these Companies
Other Reports from DnB Markets

ResearchPool Subscriptions

Get the most out of your insights

Get in touch